Suppr超能文献

肿瘤免疫微环境中的调节性树突状细胞。

Regulatory dendritic cells in the tumor immunoenvironment.

机构信息

Division of Experimental Pathology, Department of Pathology and Immunology, University of Pittsburgh Medical Center, 3550 Terrace Street, Scaife Hall S733, Pittsburgh, PA, 15261, USA.

出版信息

Cancer Immunol Immunother. 2012 Feb;61(2):223-230. doi: 10.1007/s00262-011-1138-8. Epub 2011 Nov 8.

Abstract

The tumor microenvironment is a pivotal factor in tumorigenesis, and especially in progression, as the pathogenesis of cancer critically depends on the complex interactions between various microenvironmental components. A key component of the tumor immunoenvironment is the infiltration of immune cells, which has been proven to play a dual role in tumor growth and progression. This Janus two-faced function of the tumor immunoenvironment is seen in tumor infiltration by T cells, which correlates with improved patient survival, but also with the homing of multiple subsets of immunoregulatory cells that inhibit the antitumor immune response. Regulatory dendritic cells (regDCs) have recently been shown to be induced by tumor-derived factors and represent a new and potentially important player in supporting tumor progression and suppressing the development of antitumor immune responses. Our recent data reveal that different tumor cell lines produce soluble factors that induce polarization of conventional DCs into regDCs, both in vitro and in vivo. These regDCs can suppress the proliferation of pre-activated T cells and are phenotypically and functionally different from their precursors as well as the classical immature conventional DCs. Understanding the biology of regDCs and the mechanisms of their formation in the tumor immunoenvironment will provide a new therapeutic target for re-polarizing protumorigenic immunoregulatory cells into proimmunogenic effector cells able to induce and support effective antitumor immunity.

摘要

肿瘤微环境是肿瘤发生的关键因素,特别是在进展过程中,因为癌症的发病机制严重依赖于各种微环境成分之间的复杂相互作用。肿瘤免疫环境的一个关键组成部分是免疫细胞的浸润,事实证明,免疫细胞的浸润在肿瘤生长和进展中起着双重作用。肿瘤免疫微环境的这种两面神作用表现在肿瘤浸润 T 细胞中,这与改善患者生存相关,但也与多种免疫调节细胞的归巢相关,这些细胞抑制抗肿瘤免疫反应。最近已经证明,肿瘤衍生因子可诱导调节性树突状细胞(regDC)的产生,这使其成为支持肿瘤进展和抑制抗肿瘤免疫反应发展的新的潜在重要参与者。我们最近的数据表明,不同的肿瘤细胞系在体外和体内产生可溶性因子,诱导常规树突状细胞向 regDC 极化。这些 regDC 可抑制预激活的 T 细胞增殖,其表型和功能与前体以及经典的不成熟常规树突状细胞不同。了解 regDC 的生物学及其在肿瘤免疫环境中的形成机制将为重新极化促肿瘤免疫调节细胞为能够诱导和支持有效抗肿瘤免疫的促免疫效应细胞提供新的治疗靶点。

相似文献

1
Regulatory dendritic cells in the tumor immunoenvironment.肿瘤免疫微环境中的调节性树突状细胞。
Cancer Immunol Immunother. 2012 Feb;61(2):223-230. doi: 10.1007/s00262-011-1138-8. Epub 2011 Nov 8.
8
Challenges and future perspectives of T cell immunotherapy in cancer.T细胞免疫疗法在癌症治疗中的挑战与未来展望
Immunol Lett. 2015 Aug;166(2):117-33. doi: 10.1016/j.imlet.2015.05.018. Epub 2015 Jun 19.
9
Tumor associated regulatory dendritic cells.肿瘤相关调节性树突状细胞。
Semin Cancer Biol. 2012 Aug;22(4):298-306. doi: 10.1016/j.semcancer.2012.02.010. Epub 2012 Mar 6.

引用本文的文献

5
Immunoescape the link between emphysema and lung cancer?免疫逃逸与肺气肿和肺癌之间的联系?
J Thorac Dis. 2019 Mar;11(Suppl 3):S329-S330. doi: 10.21037/jtd.2018.12.133.
8
Cancer as an immune-mediated disease.癌症作为一种免疫介导的疾病。
Immunotargets Ther. 2012 Jun 13;1:1-6. doi: 10.2147/ITT.S29834. eCollection 2012.
9
Tumor-derived factors modulating dendritic cell function.调节树突状细胞功能的肿瘤衍生因子。
Cancer Immunol Immunother. 2016 Jul;65(7):821-33. doi: 10.1007/s00262-016-1820-y. Epub 2016 Mar 16.

本文引用的文献

8
Dendritic cell control of tolerogenic responses.树突状细胞控制耐受反应。
Immunol Rev. 2011 May;241(1):206-27. doi: 10.1111/j.1600-065X.2011.01015.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验